Skip to main content

Intuitive Surgical company profile

  • ISRG · Nasdaq
  • Medical devices
  • Health Care Equipment
  • S&P 500
$443.59+0.84%Close 13 Nov 2026 · Market value $152.6B

About Intuitive Surgical

Intuitive Surgical provides a comprehensive ecosystem for minimally invasive care, combining robotic-assisted systems, instruments and accessories, customer learning, and customer support services, all connected by a digital portfolio. Its main platforms are the da Vinci surgical systems, used across a range of surgical procedures, and the Ion endoluminal system, used for minimally invasive lung biopsies. The company's products are used by surgeons, physicians, hospitals, and healthcare systems, and it offers training pathways, simulation, field service, and digital analytics to these customers. Its da Vinci and Ion products are used by customers globally, supported by a network of field service engineers across the U.S., Canada, Europe, and Asia and by distributors around the world.

A summary of the business section of the company's latest annual report, filed 3 Feb 2026.

Company facts

TickerISRG · Nasdaq
SectorMedical devices
IndustryHealth Care Equipment
IndexS&P 500
Fiscal year ends31 December
Reporting currencyUSD
CIK1035267
Latest annual report10-K, filed 3 Feb 2026

Officers and directors

NameRoleShares ownedLatest Form 4
Gary S. Guthart, Ph.D.Director1.5M · < 1%Sale under a 10b5-1 plan, 4 Nov 2026
David J. RosaChief Executive Officer (CEO) · Director439K · < 1%Shares withheld for tax, 10 Jul 2026
Mark P. BrosiusEVP &amp; Chief Mfg and Supply Cha75.5K · < 1%Sale under a 10b5-1 plan, 30 Oct 2026
Craig H. Barratt, Ph.D.Director47.9K · < 1%Option exercise, 4 Nov 2026
Henry L. CharltonEVP & Chief Commercial and Mkt37.6K · < 1%Shares withheld for tax, 28 Feb 2026
Jamie E. SamathEVP & CFO & Enterprise Technol26.3K · < 1%Option exercise, 28 Feb 2026
Amal M. JohnsonDirector25.5K · < 1%Option exercise, 30 Apr 2026
Jami Dover NachtsheimDirector21.1K · < 1%Option exercise, 30 Apr 2026
Gary H. LoebEVP &amp; Chief Legal and Complian18.0K · < 1%Sale under a 10b5-1 plan, 10 Nov 2026
Joseph C. BeeryDirector10.2K · < 1%Option exercise, 30 Apr 2026
Keith R. Leonard Jr.Director10.2K · < 1%Option exercise, 30 Apr 2026
Monica P. Reed, M.D.Director7.2K · < 1%Option exercise, 30 Apr 2026
Sreelakshmi KolliDirector1.7K · < 1%Option exercise, 30 Apr 2026
Lewis ChewDirector783 · < 1%Option exercise, 30 Apr 2026
Amy L. Ladd, M.D.Director739 · < 1%Sale under a 10b5-1 plan, 11 Aug 2026
Widman FredrikVP Corporate Controller—Option exercise, 30 Oct 2026
WADORS PATRICIA LSVP Chief Human Resources Offi—Sale under a 10b5-1 plan, 23 Oct 2026
Jeddi ImanSVP & GM da Vinci Platforms &—Sale under a 10b5-1 plan, 1 Jun 2026
Curet MyriamEVP & Chief Medical Officer—Sale under a 10b5-1 plan, 10 Mar 2026
Miller Brian EdwardEVP & Chief Digital Officer—Option exercise, 10 Nov 2025

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

ISRG in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.